Quick Answer
HNO International, Inc. reported Operating Income Loss of -$6.62 million for the year ending 2025.
- HNO International, Inc. showed a decrease of -98.2% in Operating Income Loss from 2024 to 2025.
- This data is from HNO International, Inc.'s annual report (Form 10-K), filed with the SEC on February 6, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: -$370.5 thousand | Q1 2023: -$204.4 thousand | Q2 2023: -$297.8 thousand | Q3 2023: -$459.8 thousand | Q1 2024: -$507.1 thousand | Q2 2024: -$570.9 thousand | Q3 2024: -$495.6 thousand | Q1 2025: -$5.46 million | Q2 2025: -$470.1 thousand | Q3 2025: -$498.0 thousand | Q1 2026: -$182.1 thousand.
- Over the full 4 years of available data (2022 to 2025), HNO International, Inc.'s Operating Income Loss has declined by 517.5%.
- Historical annual values: Fiscal year 2025: -$6.62 million | Fiscal year 2024: -$3.34 million | Fiscal year 2023: -$1.93 million | Fiscal year 2022: -$1.07 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: